Cargando…
Drug Repurposing for Targeting Acute Leukemia With KMT2A (MLL)—Gene Rearrangements
The treatment failure rates of acute leukemia with rearrangements of the Mixed Lineage Leukemia (MLL) gene highlight the need for novel therapeutic approaches. Taking into consideration the limitations of the current therapies and the advantages of novel strategies for drug discovery, drug repurposi...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478155/ https://www.ncbi.nlm.nih.gov/pubmed/34594227 http://dx.doi.org/10.3389/fphar.2021.741413 |